Cargando…

Association between DNA damage repair gene somatic mutations and immune‐related gene expression in ovarian cancer

BACKGROUND: Defects in DNA damage repair (DDR) system may lead to genomic instability and manifest as increased immunogenicity. DDR deficiency is prevalent in ovarian cancer (OvCa); however, the association of DDR mutation with immune profiles in OvCa remains largely unknown. This knowledge will pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Wenjuan, Shan, Boer, Zhang, Yuzi, Ren, Yulan, Liang, Shanhui, Zhao, Jing, Zhao, Zhengyi, Wang, Guoqiang, Zhao, Xiaochen, Peng, Dongxian, Bi, Rui, Cai, Shangli, Bai, Yuezong, Wang, Huaying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064027/ https://www.ncbi.nlm.nih.gov/pubmed/31991061 http://dx.doi.org/10.1002/cam4.2849

Ejemplares similares

Landscape of IDH1/2 mutations in Chinese patients with solid tumors: A pan‐cancer analysis
por: Shen, Dong, et al.
Publicado: (2021)

Hybrid Capture-based Genomic Profiling of Circulating Tumor DNA From Patients With Advanced Ovarian Cancer
por: Shen, Wenbin, et al.
Publicado: (2021)

Everolimus‐containing therapy vs conventional therapy in the treatment of refractory breast cancer patients with PI3K/AKT/mTOR mutations: A retrospective study
por: Chen, Zhanhong, et al.
Publicado: (2019)

A prognostic signature based on adenosine metabolism related genes for ovarian cancer
por: Liang, Weifeng, et al.
Publicado: (2022)

Methylation-associated silencing of miR-638 promotes endometrial carcinoma progression by targeting MEF2C
por: Ni, Jianjiao, et al.
Publicado: (2020)

Efficacy and safety of PD-1/PD-L1 inhibitors plus nab-paclitaxel for patients with non-small cell lung cancer who have progressed after platinum-based chemotherapy
por: Zhang, Fan, et al.
Publicado: (2020)

Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer
por: Xiong, Ying, et al.
Publicado: (2020)

Meta-analysis based gene expression profiling reveals functional genes in ovarian cancer
por: Zhao, Lin, et al.
Publicado: (2020)

Promoter Methylation-mediated Silencing of the MiR-192-5p Promotes Endometrial Cancer Progression by Targeting ALX1
por: Ni, Jianjiao, et al.
Publicado: (2021)

Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel
por: Wang, Zhijie, et al.
Publicado: (2019)

Characterization of hotspot exonuclease domain mutations in the DNA polymerase ϵ gene in endometrial cancer
por: Tian, Wenjuan, et al.
Publicado: (2022)

Single-cell multi-gene identification of somatic mutations and gene rearrangements in cancer
por: Grimes, Susan M, et al.
Publicado: (2023)

Identification of a Ten-Gene Signature of DNA Damage Response Pathways with Prognostic Value in Esophageal Squamous Cell Carcinoma
por: Zhuang, Weitao, et al.
Publicado: (2021)

The Tumor Mutational Burden of Chinese Advanced Cancer Patients Estimated by a 381-cancer-gene Panel
por: Zhuang, Wu, et al.
Publicado: (2018)

DNA Damage Response Gene-Based Subtypes Associated With Clinical Outcomes in Early-Stage Lung Adenocarcinoma
por: Zhao, Yang, et al.
Publicado: (2022)

Somatic mutations in early metazoan genes disrupt regulatory links between unicellular and multicellular genes in cancer
por: Trigos, Anna S, et al.
Publicado: (2019)

Interactions between dietary acrylamide intake and genes for ovarian cancer risk
por: Hogervorst, Janneke G. F., et al.
Publicado: (2017)

Anti-PD-1 Therapy plus Chemotherapy and/or Bevacizumab as Second Line or later Treatment for Patients with Advanced Non-Small Cell Lung Cancer
por: Zhang, Fan, et al.
Publicado: (2020)

The circadian rhythm and core gene Period2 regulate the chemotherapy effect and multidrug resistance of ovarian cancer through the PI3K signaling pathway
por: Wang, Zhaoxia, et al.
Publicado: (2020)

Patterns of germline and somatic mutations in 16 genes associated with mismatch repair function or containing tandem repeat sequences
por: Chang, Shih‐Ching, et al.
Publicado: (2019)

DNA damage and repair dependencies of ionising radiation modalities
por: Melia, Emma, et al.
Publicado: (2023)

Prevalence and spectrum of DNA mismatch repair gene variation in the general Chinese population
por: Zhang, Li, et al.
Publicado: (2022)

Discovery of a novel potentially transforming somatic mutation in CSF2RB gene in breast cancer
por: Rashid, Mamoon, et al.
Publicado: (2021)

Identification of the key genes associated with chemotherapy sensitivity in ovarian cancer patients
por: Zheng, Hui, et al.
Publicado: (2020)

Data mining of immune-related prognostic genes in metastatic melanoma microenvironment
por: Han, Wei, et al.
Publicado: (2020)

Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer
por: Wang, Zhenghang, et al.
Publicado: (2021)

Detection of somatic BRCA1/2 mutations in ovarian cancer – next‐generation sequencing analysis of 100 cases
por: Koczkowska, Magdalena, et al.
Publicado: (2016)

The association between adiponectin gene rs182052 polymorphism and cancer risk: a meta-analysis
por: Wu, Li-Fang, et al.
Publicado: (2020)

Identification of PPT1 as a lysosomal core gene with prognostic value in hepatocellular carcinoma
por: Tian, Wei, et al.
Publicado: (2023)

Poly-amino acids coated gold nanorod and doxorubicin for synergistic photodynamic therapy and chemotherapy in ovarian cancer cells
por: Liu, JinYing, et al.
Publicado: (2019)

Anlotinib combined with etoposide for platinum-resistant recurrent ovarian cancer: A case report
por: Sun, Li, et al.
Publicado: (2020)

Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer
por: Liang, Leilei, et al.
Publicado: (2022)

Whole‐exome sequencing of ovarian cancer families uncovers putative predisposition genes
por: Zhu, Qianqian, et al.
Publicado: (2019)

Identification of the Hub Genes Associated with the Prognosis of Ovarian Cancer Patients via Integrated Bioinformatics Analysis and Experimental Validation
por: Zhao, Yuzi, et al.
Publicado: (2021)

MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1
por: Flaum, Nicola, et al.
Publicado: (2023)

Methylation of three genes encoded by X chromosome in blood leukocytes and colorectal cancer risk
por: Tian, Tian, et al.
Publicado: (2021)

Risk factors for pneumonitis in patients treated with anti‐programmed death‐1 therapy: A case‐control study
por: Cui, Pengfei, et al.
Publicado: (2018)

Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker
por: Wang, Zhengyi, et al.
Publicado: (2020)

Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer
por: Song, Honglin, et al.
Publicado: (2021)

Assessment of mismatch repair deficiency in ovarian cancer
por: Crosbie, Emma J, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c5evcc8n66bvm7jd9c8sphvkkd